Zeev's Turnips Patch-No Politics (ZEEV)

[AKvetch]

IDEV financials Press Release just out...

http://biz.yahoo.com/bw/040816/165449_1.html

[Excerpt]

The Company reported a net loss of $18,618,000 or $0.39 per share diluted, for the three-month period ended June 30, 2004, compared with a net loss of $12,050,000, or $0.26 per share diluted, for the three-month period ended June 30, 2003. For the nine-month period ended June 30, 2004, the Company reported a net loss of $42,012,000, or $0.89 per share diluted, versus a net loss of $20,447,000, or $0.44 per share diluted, for the nine-month period ended June 30, 2003.

At June 30, 2004, the Company had cash, cash equivalents and marketable securities of approximately $192,567,000. This amount includes $150,000,000 received during the three-month period ended June 30, 2004 related to the Company's co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA(TM) (trospium chloride).